February 2020 – Clinical, regulatory and pharmacovigilance solution provider to the global life science industry Biomapas announced strategic growth in Warsaw.
With offices located in Lithuania, Switzerland, Sweden, Russia, Georgia, Ukraine and now in Poland, Biomapas provides services in 60+ countries across 4 continents. As a functional and full outsourcing solution provider, with a new office in Central Europe Biomapas will strengthen its international team and geographical coverage of its services.
Continues Biomapas growth and geographical expansion further improve our position as one of the industry forerunners.
“Biomapas is proud to bring new investment and opportunity to Central Europe and significantly deepen our presence in the region including stronger partnerships with the current and future partners there,” said Juozas Buitkus, Biomapas COO. “Clinical, regulatory and pharmacovigilance solutions aren’t limited by region or by country, and, with this new expansion, we’re increasing our commitment to enhancing our workforce and provision of overall solutions to the life science industry.”
Poland is one of the largest markets in the Central Europe region. As a solution provider, Biomapas is continually improving its standards of modern services to over exceed industry expectations and meet the ever-growing demand from the pharmaceutical industry.
“Biomapas decision to have a stronger footprint in Poland was a natural step to a vast amount and growing projects in Central Europe,” said Audrius Sveikata, Biomapas CEO. “Our continued growth is a great proof of a growing demand for flexible and customer-oriented solutions for the global life science industry.”
Biomapas is a functional and full outsourcing solution provider to the global life science industry, with key expertise in Clinical Trials, Regulatory Affairs and Pharmacovigilance. The company has a significant presence across the CEE, Nordic and CIS countries thereby offering fast and reliable patient recruitment for Phase I-IV and medical device clinical trials, while regulatory and pharmacovigilance services are provided across 4 continents. We are committed to customer service and satisfaction.